OTCMKTS:ULGX21st North Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding 21st North Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0052 0.00 (0.00 %) (As of 07/14/2020 03:41 PM ET) Add Compare Share Today's Range$0.00Now: $0.01▼$0.0150-Day Range N/A52-Week Range$0.00Now: $0.01▼$0.01Volume60,000 shsAverage Volume55,355 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta2.23 ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for 21st North. Previous Next 2.8 Community Rank Outperform Votes21st North has received 66 “outperform” votes. (Add your “outperform” vote.)Underperform Votes21st North has received 54 “underperform” votes. (Add your “underperform” vote.)Community Sentiment21st North has received 55.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about 21st North and other stocks. Vote “Outperform” if you believe ULGX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ULGX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend Yield21st North does not currently pay a dividend.Dividend Growth21st North does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 21st North insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.50% of the stock of 21st North is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.56 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ULGX Previous Symbol CUSIPN/A CIK882873 Webwww.urologix.com Phone612-475-1400Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees61 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:ULGX Rates by TradingView Receive ULGX News and Ratings via Email Sign-up to receive the latest news and ratings for ULGX and its competitors with MarketBeat's FREE daily newsletter. 21st North (OTCMKTS:ULGX) Frequently Asked Questions How has 21st North's stock been impacted by COVID-19 (Coronavirus)? 21st North's stock was trading at $0.0032 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ULGX shares have increased by 62.5% and is now trading at $0.0052. View which stocks have been most impacted by Coronavirus. Has 21st North been receiving favorable news coverage? Headlines about ULGX stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. 21st North earned a news impact score of -1.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about 21st North. Who are some of 21st North's key competitors? Some companies that are related to 21st North include Medtronic (MDT), SONOVA HLDG AG/ADR (SONVY), Masimo (MASI), Varian Medical Systems (VAR), GETINGE AB/ADR (GNGBY), LivaNova (LIVN), CONMED (CNMD), InMode (INMD), Zynex (ZYXI), Natus Medical (NTUS), BioLife Solutions (BLFS), AxoGen (AXGN), TransMedics Group (TMDX), Stereotaxis (STXS) and Viewray (VRAY). View all competitors. What other stocks do shareholders of 21st North own? Based on aggregate information from My MarketBeat watchlists, some companies that other 21st North investors own include Platinum Group Metals (PLG), Novus Therapeutics (NVUS), Nathan's Famous (NATH), Medical Marijuana (MJNA), MGM Resorts International (MGM), HRG Group (HRG), iShares MSCI Emerging Markets ETF (EEM), Cronos Group (CRON), Cannabix Technologies (BLOZF) and Barnes Group (B). Who are 21st North's key executives? 21st North's management team includes the following people: Bryon Merade, Chairman & CEO What is 21st North's stock symbol? 21st North trades on the OTCMKTS under the ticker symbol "ULGX." How do I buy shares of 21st North? Shares of ULGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is 21st North's stock price today? One share of ULGX stock can currently be purchased for approximately $0.01. What is 21st North's official website? The official website for 21st North is www.urologix.com. How can I contact 21st North? 21st North's mailing address is 14405 21ST AVE N, MINNEAPOLIS MN, 55447. The company can be reached via phone at 612-475-1400 or via email at [email protected] This page was last updated on 7/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
